Nisa Investment Advisors LLC Sells 19,248 Shares of CVS Health Corporation $CVS

Posted by Brenda Bartman on Oct 21st, 2026

Nisa Investment Advisors LLC reduced its position in shares of CVS Health Corporation (NYSE:CVS – Free Report) by 5.6% in the 3rd quarter, Holdings Channel reports. The firm owned 324,307 shares of the pharmacy operator’s stock after selling 19,248 shares during the period. Nisa Investment Advisors LLC’s holdings in CVS Health were worth $27,790,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in CVS. BlackRock Inc. acquired a new stake in shares of CVS Health in the 2nd quarter valued at $12,747,462,000. State Street Corp raised its holdings in shares of CVS Health by 26.3% during the 2nd quarter. State Street Corp now owns 74,927,064 shares of the pharmacy operator’s stock worth $7,751,205,000 after buying an additional 15,604,883 shares in the last quarter. Wellington Management Group LLP raised its holdings in shares of CVS Health by 49.8% during the 2nd quarter. Wellington Management Group LLP now owns 33,801,113 shares of the pharmacy operator’s stock worth $3,496,725,000 after buying an additional 11,233,381 shares in the last quarter. Bank of America Corp DE raised its holdings in shares of CVS Health by 148.0% during the 2nd quarter. Bank of America Corp DE now owns 23,188,670 shares of the pharmacy operator’s stock worth $2,398,868,000 after buying an additional 13,836,701 shares in the last quarter. Finally, Pzena Investment Management LLC bought a new stake in shares of CVS Health during the 2nd quarter worth $1,217,558,000. 80.66% of the stock is currently owned by institutional investors.

Key Stories Impacting CVS Health

Here are the key news stories impacting CVS Health this week:

Positive Sentiment: Opportunity to gain pharmacy customers: CVS is targeting customers displaced by Walgreens and Rite Aid store closures. The initiative could support prescription volume, retail sales and customer retention if CVS successfully converts those patients. CVS targets former Walgreens, Rite Aid customers after 1,000 stores close
Positive Sentiment: Aetna administrative improvements: CVS says Aetna is streamlining prior authorizations, approving more than 95% of eligible requests within 24 hours and expanding bundled approvals. Faster decisions could improve member and provider satisfaction while reducing administrative costs. How CVS’ Aetna Is Advancing Efforts to Reduce Administrative Burden
Positive Sentiment: MinuteClinic expansion: Three new Massachusetts locations—including the first in Boston—expand CVS’s healthcare footprint and may increase patient traffic, service revenue and cross-selling opportunities. MinuteClinic opens three new retail medical clinics
Neutral Sentiment: Leadership transition: Chief Information Officer Amaresh Siva is leaving CVS to become Alaska Airlines’ chief information technology officer. The departure may create near-term technology and AI execution uncertainty, though it does not directly change CVS’s financial outlook. Alaska Airlines taps CVS Health executive for new technology role
Negative Sentiment: Industry and valuation concerns: Coverage highlights pressure from rising medical costs across managed care, uncertainty surrounding Medicare Advantage plan availability and technical weakness after CVS raised its outlook. These issues could limit valuation expansion despite the company’s improved earnings guidance. Management raised the bar for CVS Health stock

Analysts Set New Price Targets

Several analysts recently weighed in on the company. Leerink Partners reduced their price objective on CVS Health from $119.00 to $112.00 and set an “outperform” rating on the stock in a research note on Monday, October 12th. Robert W. Baird set a $107.00 target price on CVS Health in a research note on Thursday, August 6th. Wall Street Zen cut shares of CVS Health from a “strong-buy” rating to a “buy” rating in a report on Monday. Weiss Ratings downgraded shares of CVS Health from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Friday, October 9th. Finally, Royal Bank Of Canada raised their price target on shares of CVS Health from $107.00 to $113.00 and gave the company an “outperform” rating in a research note on Thursday, July 9th. Twenty investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $107.80.

Get Our Latest Stock Report on CVS

CVS Health Stock Up 2.3%

Shares of NYSE:CVS opened at $94.77 on Wednesday. CVS Health Corporation has a 52-week low of $69.51 and a 52-week high of $110.68. The company has a market capitalization of $121.21 billion, a PE ratio of 11.82, a price-to-earnings-growth ratio of 0.86 and a beta of 0.60. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.66 and a current ratio of 0.87. The company has a fifty day moving average of $91.70 and a 200-day moving average of $93.49.

CVS Health (NYSE:CVS – Get Free Report) last released its quarterly earnings data on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share for the quarter, beating the consensus estimate of $1.87 by $0.71. CVS Health had a return on equity of 13.12% and a net margin of 1.18%. The company had revenue of $106.10 billion for the quarter, compared to the consensus estimate of $100.03 billion. During the same quarter last year, the business posted $1.81 EPS. CVS Health’s revenue for the quarter was up 7.3% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. On average, equities analysts predict that CVS Health Corporation will post 8.02 EPS for the current fiscal year.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, November 2nd. Shareholders of record on Thursday, October 22nd will be given a $0.6650 dividend. The ex-dividend date is Thursday, October 22nd. This represents a $2.66 annualized dividend and a yield of 2.8%. CVS Health’s dividend payout ratio (DPR) is currently 70.37%.

CVS Health Company Profile

(Free Report)

CVS Health Corporation (NYSE: CVS) is a diversified health care company that provides pharmacy, insurance and health services in the United States. Its businesses serve consumers, employers, health plans and health care providers through pharmacies, benefit programs, insurance coverage and clinical care services.

The company’s Pharmacy Services segment, led by CVS Caremark, manages prescription drug benefits for employers, insurers and government programs. CVS Pharmacy operates retail pharmacies and health-focused stores that dispense prescriptions and offer over-the-counter products, health and wellness merchandise, immunizations and related services.